Michio Sawada

Prevalence of hepatitis B and C virus infection in haematological malignancies and liver injury following chemotherapy

Shinji Takai, Hisashi Tsurumi, Kazuki Ando et al. · European Journal Of Haematology · 2005 · 100 citations

Medicine, Hematology, Infectious Diseases +14

Serum-soluble interleukin-2 receptor (sIL-2R) level determines clinical outcome in patients with aggressive non-Hodgkin?s lymphoma: in combination with the International Prognostic Index

Hideko Goto, Hisashi Tsurumi, Masao Takemura et al. · Journal of Cancer Research and Clinical Oncology · 2004 · 63 citations · Full text

Medicine, Immunology, Oncology +11

A phase II study of a THP‐COP regimen for the treatment of elderly patients aged 70 years or older with diffuse large B‐cell lymphoma

Hisashi Tsurumi, Takeshi Hara, Naoe Goto et al. · Hematological Oncology · 2007 · 48 citations

Medicine, Oncology, Pharmacotherapy +15

Serum-soluble Fas level determines clinical symptoms and outcome of patients with aggressive non-Hodgkin's lymphoma

Takeshi Hara, Hisashi Tsurumi, Masao Takemura et al. · American Journal of Hematology · 2000 · 43 citations

Medicine, Immunology, Oncology +12

Biweekly CHOP or THP-COP regimens in the treatment of newly diagnosed aggressive non-Hodgkin?s lymphoma

Hisashi Tsurumi, Toshiki Yamada, Michio Sawada et al. · Journal of Cancer Research and Clinical Oncology · 2004 · 42 citations · Full text

Medicine, Hematology, Oncology +5